GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography.
about
Nonhuman primate positron emission tomography neuroimaging in drug abuse researchNeuroimaging and drug taking in primatesPET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.The relationship between the dopaminergic system and depressive symptoms in cervical dystoniaWhen what you see isn't what you get: alcohol cues, alcohol administration, prediction error, and human striatal dopamine.New medications for the treatment of cocaine dependence.Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periodsDopamine in the history of the schizophrenic brain: recent contributions of brain-imaging studies.Emotional Eating Phenotype is Associated with Central Dopamine D2 Receptor Binding Independent of Body Mass IndexSchizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography methodCharacterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomographyInhibition of stimulated dopamine release and hemodynamic response in the brain through electrical stimulation of rat forepaw.What were they thinking? Cognitive states may influence [11C]raclopride binding potential in the striatum.Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjectsDopamine Autoreceptor Regulation of a Hypothalamic Dopaminergic Network.PET measurement of changes in D2/D3 dopamine receptor binding in a nonhuman primate during chronic deep brain stimulation of the bed nucleus of the stria terminalis.Racemic gamma vinyl-GABA (R,S-GVG) blocks methamphetamine-triggered reinstatement of conditioned place preference.Effects of pregnanolone in rats discriminating cocaine.Nonhuman primate models of addiction and PET imaging: dopamine system dysregulation.Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitizationCocaine-induced adaptations in metabotropic inhibitory signaling in the mesocorticolimbic system.Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist.Leg Movements During General Anesthesia.Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography studyPreliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia.
P2860
Q24607038-92FCE0FF-6539-4993-993D-732C521379D0Q24631230-B2458D49-B7FD-4CBB-AEE2-7643B5FDE666Q30403978-3A50AE0D-2DFF-4319-8C00-97B0BF134B3EQ33383360-2B6DAFEC-AE01-429E-835C-AA61336F64C9Q33841496-AF1C4D13-41EB-4CCC-9209-7CD1E84DB2D3Q34002723-D2DBE411-E469-4687-B5A3-7921673FBE49Q34152650-DAE0B2A4-B8F9-452E-BBBD-A4A38ADD5909Q35103802-D3F88603-613D-45F7-9679-531F21451438Q35236303-E63782D0-3A5D-49ED-B78E-D5A5667F423BQ35727823-956A7238-979B-4397-818A-FA4599254EBFQ36050571-5A19EB7F-D00A-43C9-8CC4-4737F1F86470Q36075795-31A191B0-384C-4350-AD19-F40BC814ACEEQ36198578-9D3772AA-1130-4957-971C-7A1B6EBF2585Q36478389-FCD43CB9-5A95-4E14-B5AC-503499EBD2B3Q36512815-A214BA41-D0C8-45C5-A7B5-780BC096FE2BQ36728072-6856060B-97AE-42C0-9AC6-79BC038C2E45Q36850413-0C467DB6-99FD-40F8-9A80-180BD7A07D78Q37089254-FFA62784-E36C-4058-8CE3-CB78F44234A9Q37216876-1C1B16E0-080F-4238-8703-9F184A798CC3Q37251129-98E7EE53-9A38-48E4-AC3E-8C5D324F587AQ37317268-38E0430B-EBCA-44B8-AEDD-2E314B237F22Q37581290-53D0D952-3AA4-48FB-A51E-D14B8DE05202Q38040253-FB7369AD-798B-4F19-939A-0EC9D870AAE7Q41998180-3A556EAE-CA66-4F55-B2A8-F775BE2706A9Q42232705-5E5212B5-3BE6-40BB-9243-F9641F16D8DDQ42745808-EDE32941-449B-4E88-A362-E1DAF98FF278Q48417176-53DCF99D-17C5-4C9F-9DC1-93E9FFC174D4
P2860
GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
GABAergic inhibition of endoge ...... positron emission tomography.
@en
GABAergic inhibition of endoge ...... positron emission tomography.
@nl
type
label
GABAergic inhibition of endoge ...... positron emission tomography.
@en
GABAergic inhibition of endoge ...... positron emission tomography.
@nl
prefLabel
GABAergic inhibition of endoge ...... positron emission tomography.
@en
GABAergic inhibition of endoge ...... positron emission tomography.
@nl
P2093
P1476
GABAergic inhibition of endoge ...... positron emission tomography.
@en
P2093
R A Ferrieri
R R MacGregor
T P Martin
P304
P356
10.1523/JNEUROSCI.12-10-03773.1992
P407
P577
1992-10-01T00:00:00Z